- Home
- TNDM
as 04-25-2025 4:00pm EST
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Upcoming Earnings Alert:
Get ready for potential market movements as Tandem Diabetes Care Inc. TNDM prepares to release earnings report on 30 Apr 2025.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | 1.1B | IPO Year: | 2013 |
| Target Price: | $44.44 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.75 - $53.69 | Next Earning Date: | 04-30-2025 |
| Revenue: | $940,203,000 | Revenue Growth: | 25.74% |
| Revenue Growth (this year): | 8.59% | Revenue Growth (next year): | 10.87% |
Stock Insider Trading Activity of Tandem Diabetes Care Inc. (TNDM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kyrillos Jean-Claude | TNDM | EVP & Chief Operating Officer | Mar 7 '25 | Buy | $18.12 | 10,538 | $190,966.47 | 10,538 |
Latest Tandem Diabetes Care Inc. News
TNDM Breaking Stock News: Dive into TNDM Ticker-Specific Updates for Smart Investing
Argus Research
5 days ago
TNDM: Lowering target price to $17.00
StockStory
5 days ago
1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar
Zacks
10 days ago
Reasons to Hold TNDM Stock in Your Portfolio for Now
Argus Research
12 days ago
TNDM: Raising target price to $19.00
MT Newswires
12 days ago
RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating
StockStory
12 days ago
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Motley Fool
15 days ago
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
Simply Wall St.
16 days ago
3 Undervalued Small Caps With Recent Insider Activity Across Regions
Compare TNDM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.